Anti-Apolipoprotein CI antibody (ab7617)


  • Product name
    Anti-Apolipoprotein CI antibody
    See all Apolipoprotein CI primary antibodies
  • Description
    Goat polyclonal to Apolipoprotein CI
  • Host species
  • Specificity
    Typically less than 1% cross reactivity against other types of apoLipoprotein was detected by ELISA. This antibody reacts with human apoLipoprotein C-I and has negligible cross-reactivity with Type A-I, A-II, B, C-II, C-III, E and J apoLipoproteins.
  • Tested applications
    Suitable for: Dot blot, ELISA, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Full length synthetic apoLipoprotein Type C-I (purified).

  • General notes
    This antibody has been used to determine that atherosclerotic lesions in the human aorta contain considerable amounts of lipoproteins. These lipoproteins were observed to be complexed with components of the extracellular matrix (especially LDL and proteoglycans). The role of these matrix-lipoprotein complexes is not entirely clear, however, animal models of atherosclerosis have shown that increased cellular proliferation and increased production of extracellular matrix components occur following injury to the intimal layer of the aorta.



Our Abpromise guarantee covers the use of ab7617 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Dot blot 1/5000 - 1/10000.
ELISA 1/4000 - 1/8000.
WB 1/1000.


  • Function
    Appears to modulate the interaction of APOE with beta-migrating VLDL and inhibit binding of beta-VLDL to the LDL receptor-related protein. Binds free fatty acids and reduces their intracellular esterification.
  • Tissue specificity
    Synthesized mainly in liver and to a minor degree in intestine. Secreted in plasma.
  • Sequence similarities
    Belongs to the apolipoprotein C1 family.
  • Cellular localization
  • Information by UniProt
  • Database links
  • Alternative names
    • APO C1 antibody
    • Apo CI antibody
    • Apo-CIB antibody
    • Apo-CIB' antibody
    • APOC 1 antibody
    • ApoC I antibody
    • ApoC-IB antibody
    • ApoC-IB' antibody
    • APOC1 antibody
    • APOC1_HUMAN antibody
    • APOC1B antibody
    • Apolipoprotein C I antibody
    • Apolipoprotein C I variant I antibody
    • Apolipoprotein C-I antibody
    • Apolipoprotein C1 antibody
    • Apolipoprotein CI antibody
    • ApolipoproteinC I antibody
    • ApolipoproteinCI antibody
    • Truncated apolipoprotein C-I antibody
    see all


ab7617 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

Thank you for your phone call. I enquired with the originator of this antibody and it turns out that ab7617 has not yet been tested for application in IHC. There was an error on the datasheet which I have updated and I apologize for any confusion. This...

Read More

Thank you for your enquiry. The Apo C1 is purified from Human plasma by density gradient ultracentrifugation and HPLC. The protocol of the purification is proprietary. A general WB protocol is followed. This product has been assayed against 1...

Read More

Thank you for your enquiry. The antibody was tested in WB (6.6kDa) and Elisa. The sample tested against was purified Human apoC1 protein. I hope this information helps, please do not hesitate to contact us if you need any more advice or informat...

Read More

I'm sorry to hear you are having problems with ab7617 in WB. I would like to recommend incubating the primary antibody overnight at 4C to promote binding of the antibody to the protein and using ECL+ as a detection kit as this is more sensitive than E...

Read More


Sign up